SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-15-053494
Filing Date
2015-07-27
Accepted
2015-07-27 19:47:30
Documents
1
Period of Report
2015-07-23

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3053
  Complete submission text file 0001104659-15-053494.txt   4487
Mailing Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 951 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6502389600
THERAVANCE INC (Issuer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THERAVANCE, INC. 951 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Faerm Michael E. (Reporting) CIK: 0001647141 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30319 | Film No.: 151008044